Literature DB >> 24378385

Cell culture in autologous fibrin scaffolds for applications in tissue engineering.

Pilar de la Puente1, Dolores Ludeña2.   

Abstract

In tissue engineering techniques, three-dimensional scaffolds are needed to adjust and guide cell growth and to allow tissue regeneration. The scaffold must be biocompatible, biodegradable and must benefit the interactions between cells and biomaterial. Some natural biomaterials such as fibrin provide a structure similar to the native extracellular matrix containing the cells. Fibrin was first used as a sealant based on pools of commercial fibrinogen. However, the high risk of viral transmission of these pools led to the development of techniques of viral inactivation and elimination and the use of autologous fibrins. In recent decades, fibrin has been used as a release system and three-dimensional scaffold for cell culture. Fibrin scaffolds have been widely used for the culture of different types of cells, and have found several applications in tissue engineering. The structure and development of scaffolds is a key point for cell culture because scaffolds of autologous fibrin offer an important alternative due to their low fibrinogen concentrations, which are more suitable for cell growth. With this review our aim is to follow methods of development, analyze the commercial and autologous fibrins available and assess the possible applications of cell culture in tissue engineering in these three-dimensional structures.
Copyright © 2013 Elsevier Inc. All rights reserved.

Keywords:  Autologous; Cell culture; Fibrin scaffolds; Fibrinogen; Tissue engineering

Mesh:

Substances:

Year:  2013        PMID: 24378385     DOI: 10.1016/j.yexcr.2013.12.017

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  29 in total

1.  Effect of Fibrin Formulation on Initial Strength of Tendon Repair and Migration of Bone Marrow Stromal Cells in Vitro.

Authors:  Kosuke Uehara; Chunfeng Zhao; Anne Gingery; Andrew R Thoreson; Kai-Nan An; Peter C Amadio
Journal:  J Bone Joint Surg Am       Date:  2015-11-04       Impact factor: 5.284

Review 2.  3D Bioprinting for Organ Regeneration.

Authors:  Haitao Cui; Margaret Nowicki; John P Fisher; Lijie Grace Zhang
Journal:  Adv Healthc Mater       Date:  2016-12-20       Impact factor: 9.933

3.  3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma.

Authors:  Pilar de la Puente; Barbara Muz; Rebecca C Gilson; Feda Azab; Micah Luderer; Justin King; Samuel Achilefu; Ravi Vij; Abdel Kareem Azab
Journal:  Biomaterials       Date:  2015-09-12       Impact factor: 12.479

4.  Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma.

Authors:  Pilar de la Puente; Micah J Luderer; Cinzia Federico; Abbey Jin; Rebecca C Gilson; Christopher Egbulefu; Kinan Alhallak; Shruti Shah; Barbara Muz; Jennifer Sun; Justin King; Daniel Kohnen; Noha Nabil Salama; Samuel Achilefu; Ravi Vij; Abdel Kareem Azab
Journal:  J Control Release       Date:  2017-11-28       Impact factor: 9.776

5.  Engineering fibrin hydrogels to promote the wound healing potential of mesenchymal stem cell spheroids.

Authors:  Kaitlin C Murphy; Jacklyn Whitehead; Dejie Zhou; Steve S Ho; J Kent Leach
Journal:  Acta Biomater       Date:  2017-10-05       Impact factor: 8.947

6.  The effect of fibrin formulation on cell migration in an in vitro tendon repair model.

Authors:  Kosuke Uehara; Chunfeng Zhao; Anne Gingery; Andrew R Thoreson; Kai-Nan An; Peter C Amadio
Journal:  J Orthop Sci       Date:  2020-08-16       Impact factor: 1.805

7.  Buffers Strongly Modulate Fibrin Self-Assembly into Fibrous Networks.

Authors:  Nicholas A Kurniawan; Thomas H S van Kempen; Stijn Sonneveld; Tilaï T Rosalina; Bart E Vos; Karin A Jansen; Gerrit W M Peters; Frans N van de Vosse; Gijsje H Koenderink
Journal:  Langmuir       Date:  2017-06-13       Impact factor: 3.882

8.  Differential regulation of macrophage inflammatory activation by fibrin and fibrinogen.

Authors:  Jessica Y Hsieh; Tim D Smith; Vijaykumar S Meli; Thi N Tran; Elliot L Botvinick; Wendy F Liu
Journal:  Acta Biomater       Date:  2016-09-20       Impact factor: 8.947

9.  Autologous or heterologous fibrin sealant scaffold: which is the better choice?

Authors:  Rui Seabra Ferreira
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2014-07-18

10.  A unique heterologous fibrin sealant (HFS) as a candidate biological scaffold for mesenchymal stem cells in osteoporotic rats.

Authors:  Patrícia Rodrigues Orsi; Fernanda Cruz Landim-Alvarenga; Luis Antônio Justulin; Ramon Kaneno; Marjorie de Assis Golim; Daniela Carvalho Dos Santos; Camila Fernanda Zorzella Creste; Eunice Oba; Leandro Maia; Benedito Barraviera; Rui Seabra Ferreira
Journal:  Stem Cell Res Ther       Date:  2017-09-29       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.